Clinical Trials Browser

OTHER × Melanoma × Blood Specimen Collection × Clear all

NCT07422805 2026-02-24

ctDNA

Phase NA Completed

Melanoma, Skin Neoplasms

NCT06608511 2025-12-17

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

Carcinoma, Basal Cell, Melanoma, Skin Neoplasms

NCT07148245 2025-11-10

Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

Melanoma

NCT03225365 2025-09-17

IMMUNONIVO

Phase NA Completed

Melanoma

NCT02831634 2025-09-08

NeoEpitope

Phase NA Completed

BreastDermatologic

Breast Neoplasms, Melanoma

NCT05819827 2025-04-27

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

DermatologicGenitourinarySarcoma

Urinary Bladder Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms

NCT02278887 2025-03-10

TIL

Phase 3 Completed

Melanoma

NCT05940311 2024-11-27

VerSiLiB

Melanoma

NCT04253080 2024-01-09

ENZYMELA

Phase NA Unknown

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

NCT05029791 2023-12-15

COLEMAN

Phase NA Recruiting

Melanoma

NCT03267381 2023-12-14

Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy

Melanoma

NCT02977052 2023-11-15

OpACIN-neo

Phase 2 Unknown

Melanoma

NCT03416933 2023-08-04

OPTIMEL

Phase NA Completed

Melanoma

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Phase 4 Unknown

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT05817149 2023-04-18

Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study

Melanoma

NCT02068196 2023-03-24

Ipi4

Phase 4 Active not recruiting

Melanoma, Neoplasms

NCT02414750 2022-11-30

REPOSIT

Phase 2 Terminated

Melanoma

NCT05062096 2022-10-04

NAKIMEL

Phase NA Unknown

Melanoma

NCT00507325 2022-09-02

Sample Collection From Melanoma Patients

Melanoma, Neoplasms

NCT05426317 2022-06-22

Onco-PDL1s/B2M

Phase NA Unknown

DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma

NCT03348891 2021-11-24

MELANFα

Phase NA Completed

Melanoma

NCT03787056 2021-07-16

ONCOPRO

Phase NA Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Endometrial Neoplasms

NCT04493723 2020-07-30

Serial Tumour Biopsies and Blood Biomarkers in Melanoma

Melanoma

NCT01916135 2020-04-27

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Phase 1 Completed

DermatologicLymphoidPlasma cellSarcoma

Carcinoma, Lymphoma, Melanoma, Sarcoma, Neoplasms, Plasma Cell

NCT01528774 2017-07-26

CTC

DermatologicGenitourinarySarcoma

Kidney Neoplasms, Melanoma, Neoplastic Cells, Circulating, Prostatic Neoplasms, Sarcoma, Somatostatinoma

NCT02105168 2016-06-10

MSN

Phase NA Unknown

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Small Cell Lung Carcinoma

NCT00615095 2011-04-20

Differential Risks for Melanoma: p16 and DNA Repair

Melanoma